ICMR plans pan-Indian survey to find out exposure of population to Covid-19

The final results of the sero-survey conducted by the ICMR in May, which focused on infections of mid-April is still under process

Coronavirus
Health worker collects nasal sample from a man for Covid-19 test, in New Delhi.
Press Trust of India New Delhi
2 min read Last Updated : Jul 10 2020 | 12:49 AM IST
The ICMR on Thursday said a nationwide sero-survey to determine the exposure of the novel coronavirus among the population will be carried out as a follow-up to a similar study conducted in May, the results of which are yet to be released.

The Indian Council of Medical Research (ICMR) will conduct a 'sero-survey' which involves testing of blood serum of people to check for the prevalence of antibodies against coronavirus infection.

The final results of the sero-survey conducted by the ICMR in May, which focused on infections of mid-April is still under process, Rajesh Bhushan, Officer on Special Duty in the Union Health Ministry said on Thursday.

"Thesero-survey that ICMR conducted across the country focused on infections of mid-April and preliminaryfindings were shared. As you know all such sero-surveillance studies or any other scientific study is subject to peer-review and those inputs are also incorporated. So that process is going on," he told reporters.

"We will be in a position to share it once that gets over," he said.


The ICMR had earlier said on the basis of the data compiled from 65 districts out of 83 districts across the country in the first part of the sero-surveillance study, 0.73 per cent of the population surveyed showed evidence of past exposure to SARS-CoV-2.

Bhushan further said the findings of the sero-survey, which has been done in Delhi by National Centre for Disease Control (NCDC) as a part of which 22,000 samples were collected from June 27 to July 5 from 11 districts, is being processed.

"In the near future, ICMR is planning a follow up sero-survey pan-India to the earlier sero-survey that they had done for mid-April infections," Bhushan explained.

Thesero-survey conducted in May had two parts -- estimating the fraction of the general population that has been infected with SARS-CoV-2 and estimating the number of people who have been infected with coronavirus in containment zones of hotspot cities, ICMR officials had earlier said.

The IgG antibodies against an infection takes around 15 days to develop in the body.

India saw a record single-day surge of 24,879 coronavirus infections, which pushed the nationwide COVID-19 tally to7,67,296 on Thursday,while the death toll climbed to21,129 with 487 new fatalities, the Health Ministry data updated at 8 am showed.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownCommunity TransmissionCoronavirus TestsCoronavirus Vaccine

Next Story